Vivimed Labs Limited - Laporan Laba Rugi (TTM)

Vivimed Labs Limited
IN ˙ NSEI ˙ INE526G01021
₹ 4.90 0.00 (0.00%)
2025-05-08
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Vivimed Labs Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
12-31
2025
03-31
2025
06-30
Revenue 9,863 10,688 8,713 6,129 4,438 2,176 2,386 2,226 2,124 2,121 1,881 1,733 1,648 1,505 1,590 1,530 1,370 1,206 1,130
Change (%) 8.36 -18.48 -29.66 -27.59 -50.96 9.62 -6.70 -4.56 -0.17 -11.31 -7.83 -4.92 -8.67 5.67 -3.79 -10.43 -11.97 -6.36
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 3,862 4,438 3,793 2,545 2,096 1,327 1,557 1,462 1,305 1,272 2,746 2,620 2,590 2,426 723 715 631 599 523
Change (%) 14.92 -14.52 -32.91 -17.65 -36.70 17.40 -6.12 -10.77 -2.50 115.84 -4.58 -1.15 -6.30 -70.22 -1.01 -11.81 -5.13 -12.63
% of Revenue 39.15 41.52 43.54 41.52 47.23 60.96 65.29 65.69 61.42 59.99 145.99 151.14 157.13 161.21 45.44 46.75 46.03 49.61 46.29
Gross Operating Profit 6,001 6,250 4,919 3,584 2,342 850 828 764 820 849 -865 -886 -942 -921 868 815 740 608 607
Change (%) 4.15 -21.29 -27.15 -34.66 -63.72 -2.54 -7.80 7.33 3.54 -201.93 2.49 6.23 -2.16 -194.19 -6.11 -9.22 -17.81 -0.18
% of Revenue 60.85 58.48 56.46 58.48 52.77 39.04 34.71 34.31 38.58 40.01 -45.99 -51.14 -57.13 -61.21 54.56 53.25 53.97 50.39 53.71
SG&A 2,371 2,659 1,969 1,425 979 375 386 343 333 335 351 336 381 384 362 346 286 284 281
Change (%) 12.17 -25.97 -27.61 -31.31 -61.74 3.11 -11.09 -3.00 0.67 4.57 -4.09 13.29 0.74 -5.78 -4.42 -17.24 -0.74 -1.14
% of Revenue 24.04 24.88 22.60 23.26 22.06 17.21 16.19 15.43 15.68 15.81 18.64 19.40 23.12 25.50 22.74 22.59 20.87 23.54 24.85
R&D
Change (%)
% of Revenue
OpEx 10,135 11,045 8,781 6,587 5,040 2,559 2,636 2,678 2,561 2,527 3,931 4,601 3,571 3,371 1,950 1,990 1,815 1,495 1,318
Change (%) 8.97 -20.49 -24.99 -23.49 -49.22 3.01 1.56 -4.35 -1.32 55.55 17.03 -22.39 -5.60 -42.14 2.05 -8.82 -17.60 -11.83
% of Revenue 102.77 103.34 100.79 107.48 113.58 117.60 110.51 120.30 120.56 119.18 209.03 265.40 216.65 223.93 122.62 130.07 132.41 123.96 116.70
Operating Income -273 -357 -69 -458 -602 -383 -251 -452 -437 -407 -2,050 -2,867 -1,922 -1,865 -360 -460 -444 -289 -189
Change (%) 31.01 -80.82 568.66 31.48 -36.41 -34.55 80.21 -3.32 -6.88 404.09 39.83 -32.95 -2.97 -80.71 27.89 -3.46 -34.94 -34.71
% of Revenue -2.77 -3.34 -0.79 -7.48 -13.58 -17.60 -10.51 -20.30 -20.56 -19.18 -109.03 -165.40 -116.65 -123.93 -22.62 -30.07 -32.41 -23.96 -16.70
Interest Expense -597 -586 -505 -485 -435 -389 -385 -396 -398 -374 -350 -372 -394 -434 -12 -29 -32
Change (%) -1.83 -13.86 -3.99 -10.38 -10.48 -0.95 2.67 0.59 -5.94 -6.50 6.42 5.75 10.14 -97.20 9.47
% of Revenue -6.06 -5.49 -5.80 -7.91 -9.79 -17.88 -16.16 -17.78 -18.74 -17.65 -18.61 -21.49 -23.90 -28.82 -0.76 -2.44 -2.86
Net Income -937 -1,112 -719 -930 -1,026 -768 -676 -875 -862 -809 -3,285 -3,219 -3,190 -3,167 -454 -451 -211 -320 -222
Change (%) 18.65 -35.34 29.33 10.41 -25.20 -11.89 29.37 -1.45 -6.23 306.21 -2.02 -0.92 -0.71 -85.65 -0.73 -53.23 51.48 -30.51
% of Revenue -9.50 -10.40 -8.25 -15.17 -23.13 -35.28 -28.36 -39.32 -40.60 -38.14 -174.69 -185.70 -193.53 -210.40 -28.57 -29.48 -15.40 -26.49 -19.66

Source: Capital IQ

Other Listings
IN:532660
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista